Chemino Pharma Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 24.60 Cr
as on 23-10-2024
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 65.73 Cr
as on 23-10-2024
- Satisfied Charges ₹ 35.00 Cr
as on 23-10-2024
- Revenue 4824.59%
(FY 2023)
- Profit 296.63%
(FY 2023)
- Ebitda -270.57%
(FY 2023)
- Net Worth 5.85%
(FY 2023)
- Total Assets 252.78%
(FY 2023)
About Chemino Pharma
The Corporate was formerly known as Chemino Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 24.60 Cr.
The company currently has active open charges totaling ₹65.73 Cr. The company has closed loans amounting to ₹35.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Chemino Pharma Limited India is Kangana Ramani as COMPANY SECRETARY. Sadashiv Shetty, Shreya Shetty, Shriraj Shetty, and One other member serve as directors at the Company.
- CIN/LLPIN
U33100MH2018PLC313189
- Company No.
313189
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
29 Aug 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Chemino Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sadashiv Shetty  | Managing Director | 29-Aug-2018 | Current |
| Kangana Ramani | Company Secretary | 01-Oct-2022 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Meghraj Shetty | Director | 01-Apr-2023 | Current |
| Shreya Shetty | Director | 27-Oct-2021 | Current |
| Shriraj Shetty | Whole-Time Director | 29-Aug-2018 | Current |
Financial Performance and Corporate Structure Insights of Chemino Pharma.
Chemino Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 4824.59% increase. The company also saw a substantial improvement in profitability, with a 296.63% increase in profit. The company's net worth moved up by a moderate rise of 5.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chemino Pharma?
In 2023, Chemino Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Heranba Industries LimitedActive 32 years 9 monthsSadashiv Shetty and Shriraj Shetty are mutual person
Heranba Crop Care Private LimitedActive 13 years 7 monthsSadashiv Shetty, Shreya Shetty and 1 more are mutual person
Heranba Organics Private LimitedActive 2 years 3 monthsSadashiv Shetty and Shriraj Shetty are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Mar 2024 | ₹8.70 M | Open |
Others Creation Date: 28 Mar 2024 | ₹9.13 Cr | Open |
Hdfc Bank Limited Creation Date: 25 Oct 2022 | ₹7.29 M | Open |
How Many Employees Work at Chemino Pharma?
Chemino Pharma has a workforce of 25 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemino Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemino Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
